Published on: December 12, 2019

Artificial Joints Market Analysis

The global Artificial Joints market is categorized as a part of the global Health Care Equipment market. The global Health Care Equipment market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our reports on global Artificial Joints market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Health Care Equipment market segmentation

Health Care Equipment which is the parent market and includes the global Artificial Joints market within its scope, can be segmented as follows:

Type

Healthcare devices
Healthcare equipment

End-user

Hospitals
Clinics
Home healthcare
Ambulatory Surgical Centers
Laboratories
Research facilities

Distribution channels

Intermediaries â€“ Distributors and retailers
Online sales
Aftermarket

Therapy areas

Cardiovascular devices
Nephrology and urology devices
Ophthalmic devices
Neurology devices
Dermatological devices
Respiratory devices
Skincare devices
Dental devices
Orthopedic devices
Gastrointestinal devices
General medical devices

Geography

Americas
Europe
Asia Pacific (APAC)
Rest of the world (RoW)

Prominent vendors in global Artificial Joints market

We provide a detailed analysis of around 25 vendors operating in the global Artificial Joints market, including some of the prominent vendors such as Aesculap AG, AK Medical, Arthrex, Biomet, Inc. Depuy Synthes (Johnson & Johnson), DJO Global, Inc. Exactech, Inc. Globus Medical, JRI Orthopaedics, Medtronic, Inc. NuVasive, Inc. SAMO, Smith & Nephew, Stryker Corp. Zimmer Holdings, and Others.

Backed with competitive intelligence and benchmarking, our research reports on the global Artificial Joints market are designed to provide entry support, customer and merger and acquisition assessment, as well as go-to-market strategy support.